Rationale and design of CONTINUITY: a Phase 4 randomized controlled trial of continued post-discharge sodium zirconium cyclosilicate treatment versus standard of care for hyperkalemia in chronic kidney disease.
James O BurtonAlaster M AllumAlpesh AminCecilia LindeEva LesénCarl MellströmJames M EudiconeManish M SoodPublished in: Clinical kidney journal (2023)
ClinicalTrials.gov identifier: NCT05347693; EudraCT: 2021-003527-14, registered on 19 October 2021.